Cite Filings / XFOR / 0000950170-25-108341

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

X4 Pharmaceuticals, Inc Filed 2025-08-13 Acc 0000950170-25-108341

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-08-18 SCHEDULE 13D Beneficial Ownership Report
2025-08-14 4 President acquired 289,881 shares (grant or award)
2025-08-14 3 Initial Statement of Ownership
2025-08-14 3 Initial Statement of Ownership
2025-08-13 8-K Material agreement · Unregistered share sale · Other events
2025-08-13 SCHEDULE 13D Beneficial Ownership Report
2025-08-12 8-K Material agreement · Unregistered share sale · Executive or director change · Other events

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…